AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.


A 3D-Printed Biomimetic Tumour Angiogenesis Model
Technology Benefits
A novel in-vitro-screening system for
prescreening of diagnostics and pharmaceuticals as well as testing drugs during tumour therapy
or analysis of tumour growth and tumour angiogenesis.
Technology Application
The present invention allows for new strategies in the 3D-cell-printing of tumour models and an alternative to animal testing. On behalf of the University of Aachen, PROvendis is offering access for commercial use in terms of a license.
Detailed Technology Description
Despite major progress in finding alternative methods to animal use in drug discovery and development, laboratory animal testing is in many instances still inevitable. The law also requires animal testing to determine the safety and efficacy of new medicines before testing in humans. To reduce the number of experimental animals, several in-vitro-screening systems have been developed using different 3D-in-vitro-tissue-engineering approaches. However, even though significant progresses have been made, there is still no satisfying in-vitro-screening system available, which might represent a suitable alternative to animal studies.
Type of Cooperation
Application Date
06/07/2015 00:00:00
Application No.
PCx US 15/323,119
PCx EP 15 747 391.9
No CN patents
ID No.

For more information, please click Here
Mobile Device